These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 16134194

  • 1. Perturbations induced by synthetic peptides from hepatitis G virus structural proteins in lipid model membranes: a fluorescent approach.
    Larios C, Casas J, Mestres C, Haro I, Alsina MA.
    Luminescence; 2005; 20(4-5):279-81. PubMed ID: 16134194
    [Abstract] [Full Text] [Related]

  • 2. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
    Herrera E, Gomara MJ, Mazzini S, Ragg E, Haro I.
    J Phys Chem B; 2009 May 21; 113(20):7383-91. PubMed ID: 19402654
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage.
    Fernández-Vidal M, Rojo N, Herrera E, Gómara MJ, Haro I.
    Biophys Chem; 2008 Jan 21; 132(1):55-63. PubMed ID: 17988786
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein.
    Larios C, Casas J, Alsina MA, Mestres C, Gómara MJ, Haro I.
    Arch Biochem Biophys; 2005 Oct 15; 442(2):149-59. PubMed ID: 16165082
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prevalence of hepatitis G virus among Tunisian blood donors].
    Mastouri M, Safer IL, Pozzetto B, Bourlet T, Khedher M.
    East Mediterr Health J; 2005 Oct 15; 11(5-6):1053-60. PubMed ID: 16761677
    [Abstract] [Full Text] [Related]

  • 10. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
    Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RT, AIDS Clinical Trial Group A5071 Study Team.
    J Infect Dis; 2006 Aug 15; 194(4):410-9. PubMed ID: 16845623
    [Abstract] [Full Text] [Related]

  • 11. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
    Berzsenyi MD, Bowden DS, Roberts SK, Revill PA.
    J Gastroenterol Hepatol; 2009 Aug 15; 24(8):1407-10. PubMed ID: 19702909
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.
    Fernández L, Chan WC, Egido M, Gómara MJ, Haro I.
    J Pept Sci; 2012 May 15; 18(5):326-35. PubMed ID: 22438139
    [Abstract] [Full Text] [Related]

  • 14. Interaction of GB virus C/hepatitis G virus synthetic peptides with lipid langmuir monolayers and large unilamellar vesicles.
    Pérez-López S, Vila-Romeu N, Asunción Alsina Esteller M, Espina M, Haro I, Mestres C.
    J Phys Chem B; 2009 Jan 08; 113(1):319-27. PubMed ID: 19195104
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interaction of lipidated GBV-C/HGV NS3 (513-522) and (505-514) peptides with phospholipids monolayer. An AFM study.
    Weroński KJ, Diez-Pérez I, Busquets MA, López-Iglesias C, Girona V, Prat J.
    Colloids Surf B Biointerfaces; 2010 Jan 01; 75(1):25-33. PubMed ID: 19765957
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.